Literature DB >> 17334749

Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse.

J D Trudeau1, T Chandler, G Soukhatcheva, C B Verchere, R Tan.   

Abstract

AIMS/HYPOTHESIS: Type 1 diabetes is a T cell-mediated autoimmune disease with a clinically silent prodrome, during which prediction and treatment of disease are theoretically possible. Using retrospective analysis, spontaneous disease in the non-obese diabetic (NOD) mouse has been correlated with islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)-reactive CD8+ T cells in the peripheral blood. In this study, we determined prospectively whether IGRP-reactive T cells in peripheral blood could predict disease occurrence. Since recurrent autoimmunity is an important contributor to transplant failure, we also determined whether failure of islet grafts (syngeneic and allogeneic) could be predicted by the presence of circulating autoreactive T cells.
MATERIALS AND METHODS: Peripheral blood samples were taken weekly from female NOD mice between the ages of 8 and 30 weeks and from NOD mice transplanted with NODscid islets. Peripheral blood cells and islet grafts were analysed for the presence of IGRP-reactive CD8+ T cells by flow cytometry.
RESULTS: Prospective analysis of peripheral blood IGRP-reactive T cells in the prediabetic period predicted disease development with a sensitivity of 100% and a specificity of 60%, resulting in positive and negative predictive values of 85 and 100%, respectively. Significant proportions of IGRP-reactive T cells were found in the grafts, but not in peripheral blood of NOD mice undergoing syngeneic and allogeneic rejection. CONCLUSIONS/
INTERPRETATION: The occurrence of spontaneous diabetes can be predicted prospectively by measuring peripheral blood autoreactive T cells. Rejection of syngeneic or allogeneic islets is associated with large populations of autoreactive CD8+ T cells within islets, suggesting that immunodominant autoreactive T cells during the prediabetic period are also responsible for autoimmune graft rejection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334749     DOI: 10.1007/s00125-007-0600-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.

Authors:  A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

Authors:  Jacqueline D Trudeau; Carolyn Kelly-Smith; C Bruce Verchere; John F Elliott; Jan P Dutz; Diane T Finegood; Pere Santamaria; Rusung Tan
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Scientific and political impediments to successful islet transplantation.

Authors:  G C Weir; S Bonner-Weir
Journal:  Diabetes       Date:  1997-08       Impact factor: 9.461

Review 4.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

5.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

6.  Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Authors:  Gabrielle G M Pinkse; Odette H M Tysma; Cees A M Bergen; Michel G D Kester; Ferry Ossendorp; Peter A van Veelen; Bart Keymeulen; Danny Pipeleers; Jan W Drijfhout; Bart O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

7.  Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.

Authors:  Carmen P Wong; Li Li; Jeffrey A Frelinger; Roland Tisch
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

8.  Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection.

Authors:  Dongmei Han; Xiumin Xu; David Baidal; Jenifer Leith; Camillo Ricordi; Rodolfo Alejandro; Norma S Kenyon
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

Review 9.  Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.

Authors:  Roland S Liblau; F Susan Wong; Lennart T Mars; Pere Santamaria
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

Review 10.  T-cell epitopes in type 1 diabetes.

Authors:  Constadina Panagiotopoulos; Jacqueline D Trudeau; Rusung Tan
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

View more
  6 in total

1.  Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets.

Authors:  Joel Montane; Loraine Bischoff; Galina Soukhatcheva; Derek L Dai; Gijs Hardenberg; Megan K Levings; Paul C Orban; Timothy J Kieffer; Rusung Tan; C Bruce Verchere
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

Review 2.  Antigen targets of type 1 diabetes autoimmunity.

Authors:  Bart O Roep; Mark Peakman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Antigen-specific T cell phenotyping microarrays using grating coupled surface plasmon resonance imaging and surface plasmon coupled emission.

Authors:  James M Rice; Lawrence J Stern; Ernest F Guignon; David A Lawrence; Michael A Lynes
Journal:  Biosens Bioelectron       Date:  2011-10-29       Impact factor: 10.618

4.  Identification of novel IGRP epitopes targeted in type 1 diabetes patients.

Authors:  Irene Jarchum; Lynn Nichol; Massimo Trucco; Pere Santamaria; Teresa P DiLorenzo
Journal:  Clin Immunol       Date:  2008-03-20       Impact factor: 3.969

5.  Structural plasticity in I-Ag7 links autoreactivity to hybrid insulin peptides in type I diabetes.

Authors:  Elena Erausquin; Pau Serra; Daniel Parras; Pere Santamaria; Jacinto López-Sagaseta
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

6.  Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes.

Authors:  Dimeng Pang; Katharine M Irvine; Ahmed M Mehdi; Helen E Thomas; Mark Harris; Emma E Hamilton-Williams; Ranjeny Thomas
Journal:  Clin Transl Immunology       Date:  2015-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.